Kofler, L.* ; Grundmann, L.* ; Gerhalter, M.* ; Prattes, M.* ; Merl-Pham, J. ; Zisser, G.* ; Grishkovskaya, I.* ; Hodirnau, V.V.* ; Vareka, M.* ; Breinbauer, R.* ; Hauck, S.M. ; Haselbach, D.* ; Bergler, H.*
The novel ribosome biogenesis inhibitor usnic acid blocks nucleolar pre-60S maturation.
Nat. Commun. 15:7511 (2024)
The formation of new ribosomes is tightly coordinated with cell growth and proliferation. In eukaryotes, the correct assembly of all ribosomal proteins and RNAs follows an intricate scheme of maturation and rearrangement steps across three cellular compartments: the nucleolus, nucleoplasm, and cytoplasm. We demonstrate that usnic acid, a lichen secondary metabolite, inhibits the maturation of the large ribosomal subunit in yeast. We combine biochemical characterization of pre-ribosomal particles with a quantitative single-particle cryo-EM approach to monitor changes in nucleolar particle populations upon drug treatment. Usnic acid rapidly blocks the transition from nucleolar state B to C of Nsa1-associated pre-ribosomes, depleting key maturation factors such as Dbp10 and hindering pre-rRNA processing. This primary nucleolar block rapidly rebounds on earlier stages of the pathway which highlights the regulatory linkages between different steps. In summary, we provide an in-depth characterization of the effect of usnic acid on ribosome biogenesis, which may have implications for its reported anti-cancer activities.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publication type
Article: Journal article
Document type
Scientific Article
Thesis type
Editors
Keywords
Cryo-em; Rna Exosome; Protein; Versatile; Pathway; Stress; Cells
Keywords plus
Language
english
Publication Year
2024
Prepublished in Year
0
HGF-reported in Year
2024
ISSN (print) / ISBN
2041-1723
e-ISSN
2041-1723
ISBN
Book Volume Title
Conference Title
Conference Date
Conference Location
Proceedings Title
Quellenangaben
Volume: 15,
Issue: 1,
Pages: ,
Article Number: 7511
Supplement: ,
Series
Publisher
Nature Publishing Group
Publishing Place
London
Day of Oral Examination
0000-00-00
Advisor
Referee
Examiner
Topic
University
University place
Faculty
Publication date
0000-00-00
Application date
0000-00-00
Patent owner
Further owners
Application country
Patent priority
Reviewing status
Peer reviewed
POF-Topic(s)
30203 - Molecular Targets and Therapies
Research field(s)
Enabling and Novel Technologies
PSP Element(s)
G-505700-001
A-630700-001
Grants
Austrian Research Promotion Agency
Boehringer Ingelheim
Austrian Science Foundation
Scientific Service Units of IST Austria
Copyright
Erfassungsdatum
2024-10-09